Skip Navigation

European Heart Journal 2000 21(4):296-305; doi:10.1053/euhj.1999.1744
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hayashi, T
Right arrow Articles by Kawamura, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayashi, T
Right arrow Articles by Kawamura, K
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Increased digitalis-like immunoreactive substances in patients with hypertrophic cardiomyopathy

T Hayashia,f1, Y Ijirib, H Tokoa, H Shimomuraa, M Okabea, F Terasakia, Y Kitauraa and K Kawamuraa

a The Third Division, Department of Medicine, Osaka Medical College, Takatsuki, Osaka, Japan
b Department of Pharmacy, Osaka Medical College Hospital, Takatsuki, Osaka, Japan

revised April 6, 1999; accepted June 1, 1999

Abstract

Aims Although increased digitalis-like immunoreactive substances have been found in cases of hypertension and heart failure, no information is available about digitalis-like immunoreactive substances in patients with hypertrophic cardiomyopathy. We investigated digitalis-like immunoreactive substances in the plasma and biopsied specimens of patients with hypertrophic cardiomyopathy.

Methods and Results In 40 patients with hypertrophic cardiomyopathy (27 with the non-obstructive type and 13 with the obstructive type), the plasma concentration of digitalis-like immunoreactive substances was studied by fluorescence polarization immunoassay. Right ventricular endomyocardial biopsy specimens were analysed immunohistochemically, using a monoclonal antibody against digoxin. An increase in digitalis-like immunoreactive substances of more than 0·2ng.ml–1in plasma was found in six of 27 patients with non-obstructive hypertrophic cardiomyopathy (22·2%) and five of 13 with obstructive hypertrophic cardiomyopathy (38·4%). Under light microscopy, positive staining against the antibody was observed heterogeneously on some cardiocytes. In non-obstructive hypertrophic cardiomyopathy, digitalis-like immunoreactive substances in the plasma correlated with the left atrial dimension and inversely with the cardiac index. In obstructive hypertrophic cardiomyopathy, plasma and myocardial digitalis-like immunoreactive substances were positively correlated; they also correlated with left ventricular end-diastolic pressures. Under electron microscopy, digitalis-like immunoreactive substances were detected at the sarcolemma in the free wall, T-tubules, intercalated discs and Z-bands of cardiocytes.

Conclusions Increased digitalis-like immunoreactive substances in plasma and cardiocytes, which may have been caused by pressure and/or volume overload, were found in patients with hypertrophic cardiomyopathy. Digitalis-like immunoreactive substances may act on the sarcolemma of cardiocytes and be transported into the cytoplasm.

Key Words: Digitalis-like immunoreactive substances, hypertrophic cardiomyopathy, immunohistochemistry, ultrastructure

f1 Correspondence: Tetsuya Hayashi, MD, PhD, The Third Division, Department of Medicine, Osaka Medical College, 2–7 Daigakumachi, Takatsuki City, Osaka 569-8686, Japan.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Hayashi, C. Yamashita, C. Matsumoto, C.-J. Kwak, K. Fujii, T. Hirata, M. Miyamura, T. Mori, A. Ukimura, Y. Okada, et al.
Role of gp91phox-containing NADPH oxidase in left ventricular remodeling induced by intermittent hypoxic stress
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2197 - H2203.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Mori, Y.-F. Chen, J. A. Feng, T. Hayashi, S. Oparil, and G. J Perry
Volume overload results in exaggerated cardiac hypertrophy in the atrial natriuretic peptide knockout mouse
Cardiovasc Res, March 1, 2004; 61(4): 771 - 779.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
T Hayashi, K Sohmiya, A Ukimura, S Endoh, T Mori, H Shimomura, M Okabe, F Terasaki, and Y Kitaura
Angiotensin II receptor blockade prevents microangiopathy and preserves diastolic function in the diabetic rat heart
Heart, October 1, 2003; 89(10): 1236 - 1242.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
O. V. Fedorova, D. E. Anderson, E. G. Lakatta, and A. Y. Bagrov
Interaction of NaCl and behavioral stress on endogenous sodium pump ligands in rats
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2001; 281(1): R352 - R358.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.